Quest Diagnostics Inc
Held by 4 superinvestors (DGX).
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Quest Diagnostics Inc (DGX) is held by 4 of the superinvestors tracked on Compounder, with a combined $325.3M in reported 13F value. The largest position belongs to Christopher Davis, where it makes up 1.5% of the portfolio.
Other notable holders by value include Robert Olstein (1.5% of its book), Ray Dalio (0.0% of its book) and Lee Ainslie (0.0% of its book).
Over the latest quarter, 0 of the tracked filers opened a new position in DGX, 1 added to existing ones, 3 trimmed, and 0 sold out entirely.
Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-03-31. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.
Superinvestors holding this security over the last 8 quarters: 4 → 4.
Early quarters may understate holder counts due to data backfill — read the slope with care.
- Value$317.1MWeight (prev→now)1.2% → 1.5% ▲
- Value$7.0MWeight (prev→now)1.4% → 1.5% ▼
- Value$680,247Weight (prev→now)0.0% → 0.0% ▼
- Value$540,121Weight (prev→now)0.0% → 0.0% ▼
Sources· SEC EDGAR 13F as of 2026-05-15
Stay Updated
Curated 13F moves and valuation insights, straight to your inbox.